The innovative device called aura6000 (Treating Obstructive Sleep Apnea using Targeted Hypoglossal Neurostimulation) is an alternative to the CPAP machine for treating sleep apnea. It has been approved by the FDA to commence an investigational device exemption (IDE) clinical study with Dr. Schalch Lepe as the principal investigator.